2026-06-29 from ctvnews.ca

Canada has approved its first generic version of the weight-loss drug Wegovy.

Health Canada announced Monday that it has authorized Svemia, a once-weekly semaglutide injection made by Canadian pharmaceutical company Apotex, for chronic weight management in people aged 12 and older “as a supplement to a reduced-calorie diet and increased physical activity for chronic weight management.”

The approval marks the first generic semaglutide injection authorized in Canada for weight loss. The drug is a generic version of Novo Nordisk’s Wegovy.

Read more here